US Patent Issued to Jazz Pharmaceuticals Research UK on Aug. 18 for "Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain" (British Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,632, issued on Aug. 18, was assigned to Jazz Pharmaceuticals Research UK Ltd. (Sittingbourne, Great Britain).

"Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain" was invented by Daniel Adam Checketts (Sittingbourne, Great Britain) and Kevin James Craig (Sittingbourne, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of cannabidiol (CBD) for the treatment of seizures associated with rare epilepsy syndromes. In particular the seizures associated with rare epilepsy syndromes that are treated are experienced in pati...